Ligand ID: 356

Drugbank ID:
Linagliptin
(DB08882)


Indication:
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus.


LIST OF BINDING INTERFACES for query '356'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
(Click on the 'View' column to view patterns on the structural viewer)

DrReposER ID PDB Ligand Drug Organism Macromolecule Pfam Res. Interface HETATM View Details
2RGU_A_356A9012rgu 356Linagliptin
(DB08882)
Homo sapiens DIPEPTIDYL PEPTIDASE 4 DPPIV_N
Peptidase_S9
16ARG A 125
GLU A 205
GLU A 206
PHE A 357
TYR A 547
TRP A 627
TRP A 629
SER A 630
TYR A 631
GLY A 632
VAL A 656
TYR A 662
TYR A 666
VAL A 711
HIS A 740
GLY A 741
356 A 901
6Y0F_A_356A8066y0f 356Linagliptin
(DB08882)
Homo sapiens PROLYL ENDOPEPTIDASE FAP DPPIV_N 17ARG A 123
GLU A 203
GLU A 204
PHE A 350
TYR A 541
TRP A 621
TRP A 623
SER A 624
TYR A 625
GLY A 626
VAL A 650
TYR A 656
TYR A 660
ASN A 704
VAL A 705
HIS A 734
TYR A 745
356 A 806
DrReposER ID PDB Ligand Drug Organism Macromolecule Pfam Res. Interface HETATM View Details